Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022
Fierce Pharma
Tue, 07/18/17 - 11:28 am
Takeda
Velcade
patents
generics
Biotech Movers: Impax Shares Jump on FDA Approval for Generic Version of Concerta
TheStreet.com
Mon, 07/17/17 - 10:06 am
biotech
Impax Labs
FDA
generics
Concerta
ADHD
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
Lilly fends off Cialis generics with new patent settlement
Fierce Pharma
Thu, 07/13/17 - 05:31 pm
Eli Lilly
Cialis
generics
patents
erectile dysfunction
Facing a critical August deadline, House passes bill to reauthorize FDA user fee programs
Endpoints
Thu, 07/13/17 - 09:19 am
FDA
user fees
generics
devices
biosimilars
Teva accuses former executive of siphoning trade secrets to her rival CEO boyfriend
Fierce Pharma
Tue, 07/11/17 - 11:21 am
Teva Pharmaceuticals
trade secrets
Apotex
generics
FDA Speeding Generic Drug Approvals: Not Just Lip Service
RAPS.org
Mon, 07/10/17 - 11:15 pm
FDA
generics
drug approvals
Scott Gottlieb
Generic drug association sues to stop state price-gouging law
BioPharma Dive
Mon, 07/10/17 - 09:25 am
generics
drug pricing
price gouging
Association for Accessible Medicines
Maryland
Generic drug industry lawsuit blasts Maryland pricing law as 'unconstitutional and invalid'
Fierce Pharma
Fri, 07/7/17 - 10:19 am
generics
Maryland
drug pricing
Pfizer Exits Brazil Venture
TheStreet.com
Thu, 07/6/17 - 11:20 pm
Pfizer
Brazil
Laboratorio Teuto Brasileiro S.A
generics
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Tue, 07/4/17 - 11:22 pm
Biogen
Tecfidera
generics
MS
multiple sclerosis
Novartis
Sandoz
Mylan Labs
FDA's first steps in drug competion plan: get more generics approved
BioPharma Dive
Thu, 06/29/17 - 09:10 am
FDA
competition
generics
Scott Gottlieb
Price-hike king Valeant could be hit hardest by FDA generics push: analyst
Fierce Pharma
Wed, 06/28/17 - 11:12 am
Valeant Pharmaceuticals
FDA
generics
drug pricing
FDA to Speed Reviews of More Generic Drugs, Offers Lists of Those With No Competition
RAPS.org
Wed, 06/28/17 - 09:37 am
FDA
generics
competition
FDA targets regulatory 'gaming' in effort to boost generic competition
BioPharma Dive
Wed, 06/21/17 - 07:35 pm
FDA
regulatory gaming
generics
competition
drug pricing
Scott Gottlieb
Increasing transparency on generic drug cost data could save $4 billion
Modern Healthcare
Sat, 06/17/17 - 07:23 pm
generics
transparency
drug pricing
PBMs
Mylan's Copaxone copy could face another hold-up with FDA info request
Fierce Pharma
Fri, 06/16/17 - 09:56 pm
Mylan
Copaxone
FDA
generics
Teva Pharmaceutical
MS
multiple sclerosis
Pharma companies fight behind-the-scenes wars over generic drugs
Stat
Fri, 06/16/17 - 09:43 am
generics
FDA approves Teva's generic copy of Truvada
BioPharma Dive
Wed, 06/14/17 - 09:04 pm
FDA
Teva Pharmaceutical
generics
Truvada
HIV
Gilead Sciences
Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space
TheStreet.com
Tue, 06/13/17 - 05:48 pm
drug pricing
patents
patent cliffs
M&A
generics
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »